Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 16, 2020 - Issue 8
Submit an article Journal homepage
2,563
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Indirect costs of adult pneumococcal disease and the productivity-based rate of return to the 13-valent pneumococcal conjugate vaccine for adults in Turkey

J. P. Sevillaa Life Sciences Group, Data for Decisions, LLC, Waltham, MA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9807-657XView further author information
ORCID Icon,
Andrew Stawasza Life Sciences Group, Data for Decisions, LLC, Waltham, MA, USAORCID Iconhttps://orcid.org/0000-0002-9902-1252View further author information
ORCID Icon,
Daria Burnesa Life Sciences Group, Data for Decisions, LLC, Waltham, MA, USAView further author information
,
Anubhav Agarwala Life Sciences Group, Data for Decisions, LLC, Waltham, MA, USAView further author information
,
Basak Hacibedelb Health Economics and Outcomes Research, Pfizer Turkey, Istanbul, TurkeyView further author information
,
Kerem Helvacioglub Health Economics and Outcomes Research, Pfizer Turkey, Istanbul, TurkeyView further author information
,
Reiko Satoc Health Economics and Outcomes Research, Pfizer Inc, Collegeville, PA, USAView further author information
&
David E. Blooma Life Sciences Group, Data for Decisions, LLC, Waltham, MA, USAView further author information
 show all
Pages 1923-1936 | Received 19 Jul 2019, Accepted 18 Dec 2019, Published online: 29 Jan 2020

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yixue Shao & Charles Stoecker. (2020) Cost-effectiveness of pneumococcal vaccines among adults over 50 years old in low- and middle-income countries: a systematic review. Expert Review of Vaccines 19:12, pages 1141-1151.
Read now

Articles from other publishers (7)

Shoroq M. Altawalbeh, Angela R. Wateska, Mary Patricia Nowalk, Chyongchiou J. Lin, Lee H. Harrison, William Schaffner, Richard K. Zimmerman & Kenneth J. Smith. (2023) Societal Cost of Racial Pneumococcal Disease Disparities in US Adults Aged 50 Years or Older. Applied Health Economics and Health Policy.
Crossref
Jie Kong, Chunguang Liang, Dongmei Fu, Liying Wang, Xiangru Yan, Sisi Li & Hui Zhang. (2023) Reliability and validity evaluation of the chinese revision of the attitude towards adult vaccination scale. BMC Public Health 23:1.
Crossref
JP Sevilla. (2022) The value of vaccines. Current Opinion in Immunology 78, pages 102243.
Crossref
David E. BloomDaniel CadaretteMaddalena Ferranna. (2021) The Societal Value of Vaccination in the Age of COVID-19. American Journal of Public Health 111:6, pages 1049-1054.
Crossref
Robert Root-Bernstein. (2021) Pneumococcal and Influenza Vaccination Rates and Pneumococcal Invasive Disease Rates Set Geographical and Ethnic Population Susceptibility to Serious COVID-19 Cases and Deaths. Vaccines 9:5, pages 474.
Crossref
Lieven Annemans, Philippe Beutels, David E. Bloom, Wilfried De Backer, Olivier Ethgen, Jeroen Luyten, Philippe Van Wilder, Lander Willem & Steven Simoens. (2021) Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader Perspective. Value in Health 24:1, pages 105-111.
Crossref
David E. Bloom, Alex Khoury, Eda Algur & J. P. Sevilla. (2020) Valuing Productive Non-market Activities of Older Adults in Europe and the US. De Economist 168:2, pages 153-181.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.